Janis Rodgers, LPN in Amery, WI - Licensed Practical Nurse

Janis Rodgers, LPN is a Licensed Practical Nurse based in Amery, Wisconsin. Janis Rodgers is licensed to practice in Wisconsin (license number 306066-31) and her current practice location is 121 2nd St, Amery, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (715) 268-8074.

NPI number for Janis Rodgers is 1629447438 and her current mailing address is 121 2nd St, Amery, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1629447438.

Contact Information

	Janis Rodgers, LPN
	121 2nd St, Amery, WI 54001-1620
	(715) 268-8074
	Not Available

Provider's Profile

Full Name	Janis Rodgers
Gender	Female
Speciality	Licensed Practical Nurse
Location	121 2nd St, Amery, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1629447438
Provider Enumeration Date: 09/22/2015
Last Update Date: 09/22/2015

Medical Identifiers

Medical identifiers for Janis Rodgers such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1629447438	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	306066-31 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Janis Rodgers is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Janis Rodgers, LPN 121 2nd St, Amery, WI 54001-1620 Ph: (715) 268-8074	Janis Rodgers, LPN 121 2nd St, Amery, WI 54001-1620 Ph: (715) 268-8074

News Archive

Link identified between early lower respiratory tract infections and development of OSA in children

Several birth cohorts have defined the pivotal role of early lower respiratory tract infections (LRTI) in the inception of pediatric respiratory conditions.

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Valensa International (Orlando, FL USA) announced today that it has initiated a broad out licensing effort for University of Illinois patent (US 5,527,533 and its foreign equivalents) for the use of the astaxanthin in eye healthcare dietary supplement applications.

Flexible Solution for High Throughput Evaporation

Series 3 HT evaporators provide an ideal solution for evaporation bottlenecks in high throughput medicinal chemistry, natural product and production labs.

Janis Rodgers, LPN - Licensed Practical Nurse in Amery, WI